| 1 |
Cani PD, Depommier C, Derrien M, Everard A, de Vos WM. Akkermansia muciniphila: paradigm for next-generation beneficial microorganisms. Nat Rev Gastroenterol Hepatol 2022. [PMID: 35641786 DOI: 10.1038/s41575-022-00631-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 2 |
Zhang Y, Hu J, Tan H, Zhong Y, Nie S. Akkermansia muciniphila, an important link between dietary fiber and host health. Current Opinion in Food Science 2022. [DOI: 10.1016/j.cofs.2022.100905] [Reference Citation Analysis]
|
| 3 |
Steimle A, Neumann M, Grant ET, Turner JD, Desai MS. Concentrated Raw Fibers Enhance the Fiber-Degrading Capacity of a Synthetic Human Gut Microbiome. Int J Mol Sci 2021;22:6855. [PMID: 34202227 DOI: 10.3390/ijms22136855] [Reference Citation Analysis]
|
| 4 |
Kumar R, Kane H, Wang Q, Hibberd A, Jensen HM, Kim H, Bak SY, Auzanneau I, Bry S, Christensen N, Friedman A, Rasinkangas P, Ouwehand AC, Forssten SD, Hasselwander O. Identification and Characterization of a Novel Species of Genus Akkermansia with Metabolic Health Effects in a Diet-Induced Obesity Mouse Model. Cells 2022;11:2084. [DOI: 10.3390/cells11132084] [Reference Citation Analysis]
|
| 5 |
Cheng T, Li C, Shen L, Wang S, Li X, Fu C, Li T, Liu B, Gu Y, Wang W, Feng B. The Intestinal Effect of Atorvastatin: Akkermansia muciniphila and Barrier Function. Front Microbiol 2021;12:797062. [PMID: 35185821 DOI: 10.3389/fmicb.2021.797062] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 6 |
Wu Z, Xu Q, Gu S, Chen Y, Lv L, Zheng B, Wang Q, Wang K, Wang S, Xia J, Yang L, Bian X, Jiang X, Zheng L, Li L. Akkermansia muciniphila Ameliorates Clostridioides difficile Infection in Mice by Modulating the Intestinal Microbiome and Metabolites. Front Microbiol 2022;13:841920. [DOI: 10.3389/fmicb.2022.841920] [Reference Citation Analysis]
|
| 7 |
Si J, Kang H, You HJ, Ko G. Revisiting the role of Akkermansia muciniphila as a therapeutic bacterium. Gut Microbes 2022;14:2078619. [PMID: 35613313 DOI: 10.1080/19490976.2022.2078619] [Reference Citation Analysis]
|
| 8 |
Xia Y, Zhang X, Jiang M, Zhang H, Wang Y, Zhang Y, Seviour R, Kong Y. In vitro co-metabolism of epigallocatechin-3-gallate (EGCG) by the mucin-degrading bacterium Akkermansia muciniphila. PLoS One 2021;16:e0260757. [PMID: 34855864 DOI: 10.1371/journal.pone.0260757] [Reference Citation Analysis]
|
